Skip to content

Proprietary Chinese Medicine for Mild COVID-19 Patients: A Registry Study

Proprietary Chinese Medicine for Mild COVID-19 Patients: A Registry Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059413
Enrollment
Unknown
Registered
2022-04-29
Start date
2022-04-18
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild COVID-19

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for mild cases in COVID-19 Diagnosis and Treatment Protocol (Trial Version 9) released by the National Health Commission; 2. 18 <= age <= 80 years old, no gender limitation; 3. Voluntarily participate in the case registration study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Respiratory bacterial infection, congenital respiratory malformation, congenital heart disease, gastroesophageal reflux, lung malformation caused by primary or secondary immunodeficiency; 2. Asthma or other chronic airway diseases that require maintenance treatment, acute respiratory bacterial infections (ie, bronchiectasis, tonsillitis, bronchitis, sinusitis, otitis media), severe pulmonary interstitial diseases; 3. Serious systemic diseases (ie, malignant tumors, autoimmune diseases, liver or kidney diseases) or surgery (splenectomy, organ transplantation) that may affect the efficacy evaluation in the opinion of the investigator; 4. Pregnant or lactating women; 5. Patients with severe mental illness or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Nucleic acid negative conversion rate in 7 days;Nucleic acid turning negative time;

Secondary

MeasureTime frame
7 days nucleic acid detection CT value up to standard rate;Recovery rate of symptoms (fever, cough, expectoration, stuffy nose, runny nose, sore throat, fatigue, diarrhea) at 7 days;Hospitalization days;Medication compliance;Conversion rate of severe disease;Adverse event rate;

Countries

China

Contacts

Public ContactQing Zhao

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

zhaoqing_1967@126.com+86 18930568563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026